Screening role of complete blood cell count indices and C reactive protein in patients who are symptomatic for COVID-19

Abstract

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations

“…Multiple biomarkers found in biofluids may potentially be utilized to identify SARS-CoV-2. Research has indicated that patients with COVID-19 have a high concentration of leukocytes, C-reactive protein, blood platelets, lymphocytes, and D-dimer [ 155 ]. A quantitative examination of molecular markers to distinguish severe COVID-19 individuals with severe symptoms were recognized due to elevated blood creatinine, urea, and cystatin C levels than patients with mild conditions [ 156 ].…”

C-reactive protein in COVID-19 patients

“…To the Editor, we were interested in the article by Ansari-Moghaddam et al referring to the role of complete blood cell counts and C-reactive protein (CRP) in COVID-19 patients [1]. We fully agree that the search for early predictive markers in both COVID-19 and other diseases is extremely important, as it allows for the detection of the disease at an early stage and the early implementation of appropriate therapy [2].…”